Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Monday, December 7, 2009, 10:30AM ET - U.S. Markets close in 5 hours and 30 minutes. Dow Up 0.35% Nasdaq Up 0.24%
Sunesis Pharmaceuticals Inc. (SNSS)At 10:12AM ET: 0.4125  Down 0.0055 (1.32%)  
MORE ON SNSS
Quotes
Charts
News & Info
Company
HereCompetitors
Analyst Coverage
Ownership
Financials

CompetitorsGet Competitors for:
DIRECT COMPETITOR COMPARISON 
SNSSAZNPvt1VION.OBIndustry
Market Cap:14.20M67.35BN/A6.64M98.96M
Employ­ees:3665,000N/A4368
Qtrly Rev Growth (yoy):-97.60%5.50%N/A-37.50%19.70%
Revenue (ttm):3.76M32.05BN/A23.00K14.01M
Gross Margin (ttm):N/A82.24%N/AN/A65.67%
EBITDA (ttm):-19.61M13.52BN/A-19.49M-12.30M
Oper Margins (ttm):-531.78%37.85%N/A-86,021.74%-137.11%
Net Income (ttm):-69.49M7.22BN/A-24.05MN/A
EPS (ttm):-2.0194.98N/A-3.067-0.33
P/E (ttm):N/A9.33N/AN/A17.26
PEG (5 yr expected):N/AN/AN/AN/A1.28
P/S (ttm):3.822.09N/A317.749.45
AZN = AstraZeneca plc
Pvt1 = Genzyme Pharmaceuticals (privately held)
VION.OB = Vion Pharmaceuticals Inc.
Industry = Biotechnology

BIOTECHNOLOGY COMPANIES RANKED BY SALES 
CompanySymbolPriceChangeMarket CapP/E
Amgen Inc.AMGN56.900.09%57.59B12.41
Genentech, Inc.Private - View Profile
Biogen Idec Inc.BIIB48.280.21%13.96B16.16
Genzyme Corp.GENZ50.230.50%13.33B28.64
Merck Serono S.A.Private - View Profile
Chiron CorporationPrivate - View Profile
Gilead Sciences Inc.GILD46.7950.44%42.11B18.10
MedImmune, Inc.Private - View Profile
Life Technologies CorporationLIFE50.710.14%9.04B1034.90
Teva Pharmaceutical Industries LimitedTEVA53.6525-0.66%47.27B49.09
View Biotechnology Industry Center

GENERIC DRUGMAKERS RANKED BY SALES 
CompanySymbolPriceChangeMarket CapP/E
Sandoz International GmbHPrivate - View Profile
Watson Pharmaceuticals Inc.WPI38.210.82%4.06B19.70
King Pharmaceuticals Inc.KG11.595-1.07%2.88BN/A
Ranbaxy Laboratories LimitedPrivate - View Profile
Mylan, Inc.MYL18.261.50%5.58B112.02
Pfizer Inc.PFE18.440001-0.27%148.80B15.32
Johnson & JohnsonJNJ64.450.14%177.82B14.08
GlaxoSmithKline plcGSK42.68-0.16%108.19B13.46
Sanofi-AventisSNY38.86-1.32%101.47BN/A
Novartis AGNVS55.730.32%126.57B16.69
View Biotechnology Industry Center

DRUGMAKERS RANKED BY SALES 
CompanySymbolPriceChangeMarket CapP/E
RHHBY.PK41.37-0.12%N/AN/A
AstraZeneca plcAZN46.450.32%67.35B9.33
Abbott LaboratoriesABT53.940.30%83.43B14.61
Bristol-Myers Squibb Co.BMY25.772.51%51.05B13.33
View Biotechnology Industry Center

NEWS ON DIRECT COMPETITORS 
AZNBristol Seeks EU OK for Apixaban
Mon 10:06am - Zacks.com
AZNBlood Thinner Battle Heats Up
Sun 1:36pm - at Forbes.com
AZNAstra-Zeneca Flies to JUPITER on Drug Results
Sun 9:04am - at Seeking Alpha
AZN[$$] Seroquel XR Gets New FDA Approval
Fri, Dec 4 - at The Wall Street Journal Online
AZNWeek Ahead: Road Upward for Stocks Is Getting Rougher
Fri, Dec 4 - at CNBC
AZNAntipsychotics, Diabetes & Kids
Fri, Dec 4 - at The Wall Street Journal Online
AZNBaxter Receives H1N1 Vaccine Order
Fri, Dec 4 - Zacks.com
AZNSignificant Deal for AZN
Fri, Dec 4 - Zacks.com
AZNAfter Rising 500%, What Did You Expect?
Fri, Dec 4 - at Motley Fool
AZNFDA Panel Recommends Antipsychotic-Drug Review of Kids' Weight Gain
Fri, Dec 4 - at The Wall Street Journal Online
AZNBiotech Stocks: Euro drugmakers lead sector stocks higher
Fri, Dec 4 - at MarketWatch
VION.OBBiotech Stock Mailbag: Hemispherx Biopharma
Fri, Dec 4 - at TheStreet.com
VION.OBVION PHARMACEUTICALS INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities
Tue, Nov 24 - EDGAR Online
VION.OBVION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
Mon, Nov 16 - EDGAR Online
VION.OBVION PHARMACEUTICALS INC Financials
Sat, Nov 14 - EDGAR Online Financials
VION.OBVion Pharmaceuticals Earnings Call scheduled for 8:30 am ET today
Thu, Nov 12 - CCBN
All Headlines for these symbols...

Need more? Get unbiased, in-depth information on public and private companies worldwide from Hoover's Online.


Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Competitors for Another Symbol: Symbol Lookup
Stock ScreenerSector Analysis